Thrivent Financial for Lutherans
PBYI icon

Thrivent Financial for Lutherans’s Puma Biotechnology PBYI Stock Holding History

Thrivent Financial for Lutherans’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-41,080
Closed -$347K – 2299
2020
Q1 		$347K Buy
+41,080
New +$399K ﹤0.01% 1908
2017
Q2 		– Sell
-26,255
Closed -$977K – 2061
2017
Q1 		$977K Buy
+26,255
New +$958K ﹤0.01% 1185
2016
Q4 		– Sell
-27,620
Closed -$1.85M – 2019
2016
Q3 		$1.85M Buy
27,620
+7,360
+36% +$372K 0.01% 901
2016
Q2 		$604K Buy
+20,260
New +$633K ﹤0.01% 1332
2015
Q4 		– Sell
-18,281
Closed -$1.38M – 1989
2015
Q3 		$1.38M Buy
18,281
+4,200
+30% +$397K 0.01% 886
2015
Q2 		$1.64M Hold
14,081
– – 0.01% 710
2015
Q1 		$3.33M Hold
14,081
– – 0.02% 576
2014
Q4 		$2.67M Sell
14,081
-9,600
-41% -$2.13M 0.01% 625
2014
Q3 		$5.65M Sell
23,681
-40,860
-63% -$8.39M 0.03% 424
2014
Q2 		$4.26M Buy
+64,541
New +$4.59M 0.02% 537

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Thrivent Financial for Lutherans's PBYI Position: Q2 2020 in Review

Thrivent Financial for Lutherans sold out of Puma Biotechnology (PBYI) in Q2 2020, closing a stake of 41,080 shares — an estimated $347K sold.

Thrivent Financial for Lutherans first reported a position in PBYI in Q2 2014 and held it in 10 quarters. The position peaked at $5.65M in Q3 2014. 128 funds tracked by Wall St. Rank hold PBYI as of Q2 2020.

  • Thrivent Financial for Lutherans reported no remaining Puma Biotechnology position as of Q2 2020 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 41,080 Puma Biotechnology shares in Q2 2020, an estimated $347K.
  • Thrivent Financial for Lutherans first reported a position in Puma Biotechnology in Q2 2014 and held it in 10 quarters.
  • Thrivent Financial for Lutherans's Puma Biotechnology position peaked at $5.65M in Q3 2014.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2020.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2020, filed 12 Aug 2020.